FCA

On Monday, May 19, the U.S. Department of Justice issued a memorandum announcing the launch of a new “Civil Rights Fraud Initiative,” aimed at investigating and pursuing claims under the False Claims [...]

In another notable False Claims Act development, a Massachusetts federal district court recently held that, when the United States intervenes in a relator’s qui tam lawsuit under the False Claims Act (“FCA”) [...]

Laboratory Companies’ Unnecessary COVID-19 Testing at Nursing Homes Resulted in Fraudulently Billing Medicare The U.S. Department of Justice (DOJ) remains focused on one of its top enforcement priorities for 2024: detecting, investigating [...]

Disclosure Requirements Remain Focus of NIH Federal funding agencies continue to emphasize the importance of researchers—and research institutions—disclosing all foreign funding and ties in federal grant applications. On May 17, the Cleveland [...]

Feldesman Partners Rosie Dawn Griffin and Mindy B. Pava will present during the Society of Research Administrators International (SRAI) Virtual Research Administration Conference this Spring.   Their session, “Year 2024 Expected Enforcement Priorities: [...]

Washington, DC – Feldesman Leifer LLP (Feldesman) proudly welcomes Stephen Kuperberg as a Partner in the firm’s Health Care and Litigation & Government Investigations Practice Groups effective March 18, 2024. With over [...]

The federal False Claims Act (FCA) is one of the government’s strongest enforcement tools, annually resulting in billions of dollars clawed back to the United States as a result of the statute’s [...]

In a unanimous opinion issued Thursday, June 1, the U.S. Supreme Court retained the current “scienter” or “knowledge standard” governing False Claims Act (“FCA”) cases, and, in doing so, offered guidance to [...]

The United States Environmental Protection Agency (EPA) has a new Inspector General (IG), following an extended period of oversight by acting IGs.  Sean O’Donnell was confirmed on December 19, 2019 to lead [...]

Yesterday, Judge Chen of the U.S. District Court for the Northern District of California dismissed claims alleging that Gilead Sciences, Inc. defrauded the United States government and violated the False Claims Act [...]